1CM
1492 Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,005
| Closed | -$488K | – | 109 |
|
|
2022
Q4 | $488K | Hold |
12,005
| – | – | 0.31% | 74 |
|
|
2022
Q3 | $785K | Sell |
12,005
-3
| -0% | -$196 | 0.57% | 61 |
|
|
2022
Q2 | $730K | Buy |
+12,008
| New | +$730K | 0.48% | 71 |
|
|
2021
Q4 | – | Sell |
-9,256
| Closed | -$1.04M | – | 102 |
|
|
2021
Q3 | $1.04M | Sell |
9,256
-68
| -0.7% | -$7.61K | 0.52% | 59 |
|
|
2021
Q2 | $1.51M | Buy |
9,324
+5,924
| +174% | +$959K | 0.77% | 50 |
|
|
2021
Q1 | $414K | Sell |
3,400
-80
| -2% | -$9.74K | 0.24% | 65 |
|
|
2020
Q4 | $533K | Sell |
3,480
-5,803
| -63% | -$889K | 0.31% | 68 |
|
|
2020
Q3 | $776K | Buy |
9,283
+731
| +9% | +$61.1K | 0.58% | 47 |
|
|
2020
Q2 | $628K | Sell |
8,552
-43
| -0.5% | -$3.16K | 0.54% | 48 |
|
|
2020
Q1 | $365K | Sell |
8,595
-194
| -2% | -$8.24K | 0.44% | 60 |
|
|
2019
Q4 | $535K | Buy |
+8,789
| New | +$535K | 0.47% | 59 |
|
|
2019
Q1 | – | Sell |
-15,633
| Closed | -$447K | – | 82 |
|
|
2018
Q4 | $447K | Sell |
15,633
-2,132
| -12% | -$61K | 0.4% | 63 |
|
|
2018
Q3 | $788K | Buy |
+17,765
| New | +$788K | 0.51% | 61 |
|